SIGA News and Press, SIGA Technologies Inc. From 03/11/24

2024-03-11 17:35:46 ET Major earnings expected after the bell on Tuesday include: Clover Health Investments, Corp. ( CLOV ) SurgePays ( SURG ) Heron Therapeutics ( HRTX ) Qifu Technology ( QFIN ) Veritone ( VERI ) Read the full article on Se...

Gevo Inc. (GEVO) is expected to report $-0.05 for Q4 2023 Harvard Bioscience Inc. (HBIO) is expected to report $0.03 for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 DFI Retail Group Holdings Limited ADR (DFIHY) is expected to report for quarter end 2...

NEW YORK, March 05, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, March 12 th , ...

2024-01-22 07:50:40 ET More on SIGA Technologies SIGA Technologies: Impressive Net Sales Guidance, FDA Approval, And Cheap SIGA Technologies, Inc. (SIGA) Q3 2023 Earnings Call Transcript Historical earnings data for SIGA Technologies Financial information for...

NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Diem Nguyen, Ph.D., will join the Company as chief executive officer (CEO), effective January 27, 2024, ...

2024-01-11 11:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-12-26 09:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-11-20 00:14:35 ET Summary SIGA Technologies delivered impressive net sales expectations for Q4 and is working to expand its treatment of human smallpox in new jurisdictions. The company has regulatory approvals for its oral antiviral drug Tpoxx and is exploring expanding its ...

2023-11-07 21:36:04 ET SIGA Technologies, Inc. (SIGA) Q3 2023 Earnings Conference Call November 7, 2023 04:30 PM ET Company Participants Phillip Louis Gomez - Chief Executive Officer Dennis Hruby - Executive Vice President and Chief Scientific Officer Jay Varma -...

2023-11-07 16:24:35 ET More on SIGA Technologies Historical earnings data for SIGA Technologies Financial information for SIGA Technologies For further details see: SIGA Technologies GAAP EPS of -$0.01, revenue of $9.23M